what's a glp 1 medication GLP-1 How Long Does It Take
Description
A similar 30-week open-label trial comparing exenatide twice daily with exenatide once weekly also demonstrated significant DTSQ treatment satisfaction changes at 30 weeks with willingness to continue current treatment and perceived hypoglycemia frequency, both favoring the once weekly formulation [Best et al
95% CI, 0.380.98) and cardiovascular mortality (RR 0.72
Abstract The ever-increasing number of drugs available to treat type 2 diabetes and the complexity of patients with this condition present a constant challenge when it comes to identifying the most appropriate treatment approach
doi: 10.1210/endo.139.7.6092
After this time, and if the person is able to tolerate the medication, the dose should be increased to 7mg daily
